Morten Harboe

  • Professor emeritus

Visit the Mollnes group home page at UiO for more information


Original articles

Harboe M, Johnson C, Nymo S, Ekholt K, Schjalm C, Lindstad JK, Pharo A, Hellerud BC, Nilsson Ekdahl K, Mollnes TE, Nilsson PH (2017)
Properdin binding to complement activating surfaces depends on initial C3b deposition
Proc Natl Acad Sci U S A, 114 (4), E534-E539
DOI 10.1073/pnas.1612385114, PubMed 28069958

Harboe M, Garred P, Lindstad JK, Pharo A, Müller F, Stahl GL, Lambris JD, Mollnes TE (2012)
The role of properdin in zymosan- and Escherichia coli-induced complement activation
J Immunol, 189 (5), 2606-13
DOI 10.4049/jimmunol.1200269, PubMed 22851705

Wiker HG, Mustafa T, Bjune GA, Harboe M (2010)
Evidence for waning of latency in a cohort study of tuberculosis
BMC Infect Dis, 10, 37
DOI 10.1186/1471-2334-10-37, PubMed 20178619

Hellerud BC, Aase A, Herstad TK, Naess LM, Kristiansen LH, Trøseid AM, Harboe M, Lappegård KT, Brandtzaeg P, Høiby EA, Mollnes TE (2009)
Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies
Infect Immun, 78 (2), 802-9
DOI 10.1128/IAI.01044-09, PubMed 19933829

Harboe M, Garred P, Karlstrøm E, Lindstad JK, Stahl GL, Mollnes TE (2009)
The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification
Mol Immunol, 47 (2-3), 373-80
DOI 10.1016/j.molimm.2009.09.005, PubMed 19800125

Lappegård KT, Christiansen D, Pharo A, Thorgersen EB, Hellerud BC, Lindstad J, Nielsen EW, Bergseth G, Fadnes D, Abrahamsen TG, Høiby EA, Schejbel L, Garred P, Lambris JD, Harboe M, Mollnes TE (2009)
Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature
Proc Natl Acad Sci U S A, 106 (37), 15861-6
DOI 10.1073/pnas.0903613106, PubMed 19717455

Salvesen B, Nielsen EW, Harboe M, Saugstad OD, Mollnes TE (2008)
Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood
Mol Immunol, 46 (4), 688-94
DOI 10.1016/j.molimm.2008.09.001, PubMed 18950866

Norheim G, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Merid Y, Høiby EA, Caugant DA, Fritzsønn E, Tangen T, Melak B, Berhanu D, Harboe M, Kolberg J, Rosenqvist E (2008)
Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci
Clin Vaccine Immunol, 15 (5), 863-71
DOI 10.1128/CVI.00252-07, PubMed 18337382

Norheim G, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Merid Y, Høiby EA, Caugant DA, Fritzsønn E, Tangen T, Alebel T, Berhanu D, Harboe M, Rosenqvist E (2007)
Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7
Clin Vaccine Immunol, 14 (4), 451-63
DOI 10.1128/CVI.00008-07, PubMed 17301215

Harboe M (2006)
[The new face of tuberculosis in Norway]
Tidsskr Nor Laegeforen, 126 (20), 2682-3
PubMed 17057770

Harboe M (2006)
[This is not our medical ethic]
Tidsskr Nor Laegeforen, 126 (17), 2283
PubMed 16967071

Harboe M, Garred P, Borgen MS, Stahl GL, Roos A, Mollnes TE (2006)
Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions
Clin Exp Immunol, 144 (3), 512-20
DOI 10.1111/j.1365-2249.2006.03072.x, PubMed 16734621

Norheim G, Rosenqvist E, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Høiby EA, Alebel T, Berhanu D, Merid Y, Harboe M, Caugant DA (2006)
Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989
J Clin Microbiol, 44 (3), 861-71
DOI 10.1128/JCM.44.3.861-871.2006, PubMed 16517868

Harboe M, Ulvund G, Vien L, Fung M, Mollnes TE (2004)
The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation
Clin Exp Immunol, 138 (3), 439-46
DOI 10.1111/j.1365-2249.2004.02627.x, PubMed 15544620

Habte A, Geletu M, Olobo JO, Kidane D, Negesse Y, Yassin MA, Kifle B, Abate G, Harboe M, Aseff A (2004)
T cell mediated immune responses in patients with tuberculous lymphadenitis from Butajira, southern Ethiopia
Ethiop Med J, 42 Suppl 1, 29-35
PubMed 16895017

Abebe M, Lakew M, Kidane D, Lakew Z, Kiros K, Harboe M (2004)
Female genital tuberculosis in Ethiopia
Ethiop Med J, 42 Suppl 1, 37-41
PubMed 16895018

Abebe M, Lakew M, Kidane D, Lakew Z, Kiros K, Harboe M (2004)
Female genital tuberculosis in Ethiopia
Int J Gynaecol Obstet, 84 (3), 241-6
DOI 10.1016/j.ijgo.2003.11.002, PubMed 15001372

Harboe M, Das AK, Mitra D, Ulvund G, Ahmad S, Harkness RE, Das D, Mustafa AS, Wiker HG (2004)
Immunodominant B-cell epitope in the Mce1A mammalian cell entry protein of Mycobacterium tuberculosis cross-reacting with glutathione S-transferase
Scand J Immunol, 59 (2), 190-7
DOI 10.1111/j.0300-9475.2004.01383.x, PubMed 14871296

Beyene D, Aseffa A, Harboe M, Kidane D, Macdonald M, Klatser PR, Bjune GA, Smith WC (2003)
Nasal carriage of Mycobacterium leprae DNA in healthy individuals in Lega Robi village, Ethiopia
Epidemiol Infect, 131 (2), 841-8
DOI 10.1017/s0950268803001079, PubMed 14596524

Das AK, Mitra D, Harboe M, Nandi B, Harkness RE, Das D, Wiker HG (2003)
Predicted molecular structure of the mammalian cell entry protein Mce1A of Mycobacterium tuberculosis
Biochem Biophys Res Commun, 302 (3), 442-7
DOI 10.1016/s0006-291x(03)00116-5, PubMed 12615052

Tollefsen S, Pollock JM, Lea T, Harboe M, Wiker HG (2003)
T- and B-cell epitopes in the secreted Mycobacterium bovis antigen MPB70 in mice
Scand J Immunol, 57 (2), 151-61
DOI 10.1046/j.1365-3083.2003.01211.x, PubMed 12588661

Yassin MA, Olobo JO, Kidane D, Negesse Y, Shimeles E, Tadesse A, Demissie A, Britton S, Harboe M, Aseffa A, Abate G (2003)
Diagnosis of tuberculous lymphadenitis in Butajira, rural Ethiopia
Scand J Infect Dis, 35 (4), 240-3
DOI 10.1080/00365540310004027, PubMed 12839151

Harboe M, Christensen A, Ahmad S, Ulvund G, Harkness RE, Mustafa AS, Wiker HG (2002)
Cross-reaction between mammalian cell entry (Mce) proteins of Mycobacterium tuberculosis
Scand J Immunol, 56 (6), 580-7
DOI 10.1046/j.1365-3083.2002.01172.x, PubMed 12472669

Kidane D, Olobo JO, Habte A, Negesse Y, Aseffa A, Abate G, Yassin MA, Bereda K, Harboe M (2002)
Identification of the causative organism of tuberculous lymphadenitis in ethiopia by PCR
J Clin Microbiol, 40 (11), 4230-4
DOI 10.1128/jcm.40.11.4230-4234.2002, PubMed 12409403

Tollefsen S, Tjelle T, Schneider J, Harboe M, Wiker H, Hewinson G, Huygen K, Mathiesen I (2002)
Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation
Vaccine, 20 (27-28), 3370-8
DOI 10.1016/s0264-410x(02)00289-x, PubMed 12213407

Harboe M, Whelan AO, Ulvund G, McNair J, Pollock JM, Hewinson RG, Wiker HG (2002)
Generation of antibodies to the signal peptide of the MPT83 lipoprotein of Mycobacterium tuberculosis
Scand J Immunol, 55 (1), 82-7
DOI 10.1046/j.1365-3083.2002.01030.x, PubMed 11841695

Johnson S, Brusasca P, Lyashchenko K, Spencer JS, Wiker HG, Bifani P, Shashkina E, Kreiswirth B, Harboe M, Schluger N, Gomez M, Gennaro ML (2001)
Characterization of the secreted MPT53 antigen of Mycobacterium tuberculosis
Infect Immun, 69 (9), 5936-9
DOI 10.1128/iai.69.9.5936-5939.2001, PubMed 11500477

Lyashchenko KP, Wiker HG, Harboe M, McNair J, Komissarenko SV, Pollock JM (2001)
Novel monoclonal antibodies against major antigens of Mycobacterium bovis
Scand J Immunol, 53 (5), 498-502
DOI 10.1046/j.1365-3083.2001.00914.x, PubMed 11309158

Hernández-Pando R, Jeyanathan M, Mengistu G, Aguilar D, Orozco H, Harboe M, Rook GA, Bjune G (2000)
Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection
Lancet, 356 (9248), 2133-8
DOI 10.1016/s0140-6736(00)03493-0, PubMed 11191539

Smith WC, Smith C, Cree I, Klatser P, Harboe M, Bjune G, Edward VK, MILEP2 Study Grp (2000)
Approaches to studying the transmission of Mycobacterium leprae
Lepr. Rev., 71 S, S26-S29

Harboe M, Christensen A, Haile Y, Ulvund G, Ahmad S, Mustafa AS, Wiker HG (1999)
Demonstration of expression of six proteins of the mammalian cell entry (mce1) operon of Mycobacterium tuberculosis by anti-peptide antibodies, enzyme-linked immunosorbent assay and reverse transcription-polymerase chain reaction
Scand J Immunol, 50 (5), 519-27
DOI 10.1046/j.1365-3083.1999.00632.x, PubMed 10564555

Ahmad S, Akbar PK, Wiker HG, Harboe M, Mustafa AS (1999)
Cloning, expression and immunological reactivity of two mammalian cell entry proteins encoded by the mce1 operon of Mycobacterium tuberculosis
Scand J Immunol, 50 (5), 510-8
DOI 10.1046/j.1365-3083.1999.00631.x, PubMed 10564554

Wiker HG, Spierings E, Kolkman MA, Ottenhoff TH, Harboe M (1999)
The mammalian cell entry operon 1 (mce1) of mycobacterium leprae and mycobacterium tuberculosis
Microb Pathog, 27 (3), 173-7
DOI 10.1006/mpat.1999.0298, PubMed 10455007

Wiker HG, Michell SL, Hewinson RG, Spierings E, Nagai S, Harboe M (1999)
Cloning, expression and significance of MPT53 for identification of secreted proteins of Mycobacterium tuberculosis
Microb Pathog, 26 (4), 207-19
DOI 10.1006/mpat.1998.0267, PubMed 10089161

Harboe M, Wiker HG (1999)
Searching for secreted proteins of Mycobacterium leprae
Indian J Lepr, 71 (1), 19-35
PubMed 10439323

Harboe M, Wiker HG (1998)
Secreted proteins of Mycobacterium leprae
Scand J Immunol, 48 (6), 577-84
DOI 10.1046/j.1365-3083.1998.00451.x, PubMed 9874491

Wiker HG, Lyashchenko KP, Aksoy AM, Lightbody KA, Pollock JM, Komissarenko SV, Bobrovnik SO, Kolesnikova IN, Mykhalsky LO, Gennaro ML, Harboe M (1998)
Immunochemical characterization of the MPB70/80 and MPB83 proteins of Mycobacterium bovis
Infect Immun, 66 (4), 1445-52
DOI 10.1128/IAI.66.4.1445-1452.1998, PubMed 9529066

Hetland G, Wiker HG, Høgåsen K, Hamasur B, Svenson SB, Harboe M (1998)
Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis
Clin Diagn Lab Immunol, 5 (2), 211-8
DOI 10.1128/CDLI.5.2.211-218.1998, PubMed 9521145

Harboe M, Malin AS, Dockrell HS, Wiker HG, Ulvund G, Holm A, Jørgensen MC, Andersen P (1998)
B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis
Infect Immun, 66 (2), 717-23
DOI 10.1128/IAI.66.2.717-723.1998, PubMed 9453632

Jansen JH, Høgåsen K, Harboe M, Hovig T (1998)
In situ complement activation in porcine membranoproliferative glomerulonephritis type II
Kidney Int, 53 (2), 331-49
DOI 10.1046/j.1523-1755.1998.00765.x, PubMed 9461093

Harboe M (1998)
Protective immunity to intracellular parasites--a focus for vaccine research and a challenge to immunization programmes
Dev Biol Stand, 92, 145-7
PubMed 9554268

Sethna KB, Mistry NF, Dholakia Y, Antia NH, Harboe M (1998)
Longitudinal trends in serum levels of mycobacterial secretory (30 kD) and cytoplasmic (65 kD) antigens during chemotherapy of pulmonary tuberculosis patients
Scand J Infect Dis, 30 (4), 363-9
DOI 10.1080/00365549850160657, PubMed 9817516

Harboe M, Wiker HG, Ulvund G, Lund-Pedersen B, Andersen AB, Hewinson RG, Nagai S (1998)
MPB70 and MPB83 as indicators of protein localization in mycobacterial cells
Infect Immun, 66 (1), 289-96
DOI 10.1128/IAI.66.1.289-296.1998, PubMed 9423870

Mollnes TE, Andreassen IH, Høgåsen K, Hack CE, Harboe M (1997)
Effect of whole and fractionated intravenous immunoglobulin on complement in vitro
Mol Immunol, 34 (10), 719-29
DOI 10.1016/s0161-5890(97)00091-6, PubMed 9430199

Høgåsen K, Jansen JH, Harboe M (1997)
Eradication of porcine factor H deficiency in Norway
Vet Rec, 140 (15), 392-5
DOI 10.1136/vr.140.15.392, PubMed 9141221

Moen O, Høgåsen K, Fosse E, Dregelid E, Brockmeier V, Venge P, Harboe M, Mollnes TE (1997)
Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass
Ann Thorac Surg, 63 (1), 105-11
DOI 10.1016/s0003-4975(96)00743-6, PubMed 8993250

Mollnes TE, Harboe M (1996)
Clinical immunology
BMJ, 312 (7044), 1465-9
DOI 10.1136/bmj.312.7044.1465, PubMed 8664630

Harboe M, Andersen P, Colston MJ, Gicquel B, Hermans PW, Ivanyi J, Kaufmann SH (1996)
European Commission COST/STD Initiative. Report of the expert panel IX. Vaccines against tuberculosis
Vaccine, 14 (7), 701-16
DOI 10.1016/s0264-410x(96)90051-1, PubMed 8799982

Wiker HG, Nagai S, Hewinson RG, Russell WP, Harboe M (1996)
Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv
Scand J Immunol, 43 (4), 374-80
DOI 10.1046/j.1365-3083.1996.d01-61.x, PubMed 8668915

Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P (1996)
Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG
Infect Immun, 64 (1), 16-22
DOI 10.1128/IAI.64.1.16-22.1996, PubMed 8557334

Mollnes TE, Riesenfeld J, Garred P, Nordström E, Høgåsen K, Fosse E, Götze O, Harboe M (1995)
A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin
Artif Organs, 19 (9), 909-17
DOI 10.1111/j.1525-1594.1995.tb02450.x, PubMed 8687297

Harboe M (1995)
[Electromagnetic fields and health]
Tidsskr Nor Laegeforen, 115 (20), 2522-3
PubMed 7676413

Harboe M, Nagai S, Wiker HG, Sletten K, Haga S (1995)
Homology between the MPB70 and MPB83 proteins of Mycobacterium bovis BCG
Scand J Immunol, 42 (1), 46-51
DOI 10.1111/j.1365-3083.1995.tb03624.x, PubMed 7631144

Mollnes TE, Høgåsen K, Hoaas BF, Michaelsen TE, Garred P, Harboe M (1995)
Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the IG isotype and its C1 binding properties
Scand J Immunol, 41 (5), 449-56
DOI 10.1111/j.1365-3083.1995.tb03591.x, PubMed 7725063

Hermans PW, Abebe F, Kuteyi VI, Kolk AH, Thole JE, Harboe M (1995)
Molecular and immunological characterization of the highly conserved antigen 84 from Mycobacterium tuberculosis and Mycobacterium leprae
Infect Immun, 63 (3), 954-60
DOI 10.1128/IAI.63.3.954-960.1995, PubMed 7868268

Høgåsen K, Jansen JH, Mollnes TE, Hovdenes J, Harboe M (1995)
Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency
J Clin Invest, 95 (3), 1054-61
DOI 10.1172/JCI117751, PubMed 7883953

Ostenstad B, Sioud M, Schlichting E, Lea T, Harboe M (1995)
Freshly isolated tumour-infiltrating T-lymphocytes have a high cytotoxic potential, as measured by their ability to induce apoptosis in the target cell
Scand J Immunol, 41 (1), 42-8
DOI 10.1111/j.1365-3083.1995.tb03531.x, PubMed 7824887

Høgåsen K, Mollnes TE, Harboe M, Götze O, Hammer HB, Oppermann M (1995)
Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid
J Rheumatol, 22 (1), 24-8
PubMed 7535360

Ostenstad B, Harboe M, Lea T (1994)
Differential effects of cyclic adenosine 3',5'-monophosphate on T cell cytotoxicity
Eur J Immunol, 24 (9), 2150-4
DOI 10.1002/eji.1830240932, PubMed 8088333

Ostenstad B, Sioud M, Lea T, Schlichting E, Harboe M (1994)
Limited heterogeneity in the T-cell receptor V-gene usage in lymphocytes infiltrating human colorectal tumours
Br J Cancer, 69 (6), 1078-82
DOI 10.1038/bjc.1994.211, PubMed 8198973

Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A (1994)
Dual role of mannan-binding protein in infections: another case of heterosis?
Eur J Immunogenet, 21 (2), 125-31
DOI 10.1111/j.1744-313x.1994.tb00183.x, PubMed 9098426

Ostenstad B, Lea T, Schlichting E, Harboe M (1994)
Human colorectal tumour infiltrating lymphocytes express activation markers and the CD45RO molecule, showing a primed population of lymphocytes in the tumour area
Gut, 35 (3), 382-7
DOI 10.1136/gut.35.3.382, PubMed 8150352

Wieles B, van Agterveld M, Janson A, Clark-Curtiss J, Rinke de Wit T, Harboe M, Thole J (1994)
Characterization of a Mycobacterium leprae antigen related to the secreted Mycobacterium tuberculosis protein MPT32
Infect Immun, 62 (1), 252-8
DOI 10.1128/IAI.62.1.252-258.1994, PubMed 8262636

Huygen K, Drowart A, Harboe M, ten Berg R, Cogniaux J, Van Vooren JP (1993)
Influence of genes from the major histocompatibility complex on the antibody repertoire against culture filtrate antigens in mice infected with live Mycobacterium bovis BCG
Infect Immun, 61 (6), 2687-93
DOI 10.1128/IAI.61.6.2687-2693.1993, PubMed 8500908

Rambukkana A, Burggraaf JD, Faber WR, Harboe M, Teeling P, Krieg S, Das PK (1993)
The mycobacterial secreted antigen 85 complex possesses epitopes that are differentially expressed in human leprosy lesions and Mycobacterium leprae-infected armadillo tissues
Infect Immun, 61 (5), 1835-45
DOI 10.1128/IAI.61.5.1835-1845.1993, PubMed 7682995

Li H, Ulstrup JC, Jonassen TO, Melby K, Nagai S, Harboe M (1993)
Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG
Infect Immun, 61 (5), 1730-4
DOI 10.1128/IAI.61.5.1730-1734.1993, PubMed 8478061

Rambukkana A, Das PK, Kolk AH, Burggraaf JD, Kuijper S, Harboe M (1993)
Identification of a novel 27-kDa protein from Mycobacterium tuberculosis culture fluid by a monoclonal antibody specific for the Mycobacterium tuberculosis complex
Scand J Immunol, 37 (4), 471-8
DOI 10.1111/j.1365-3083.1993.tb03321.x, PubMed 8469931

Høgåsen K, Mollnes TE, Tschopp J, Harboe M (1993)
Quantitation of vitronectin and clusterin. Pitfalls and solutions in enzyme immunoassays for adhesive proteins
J Immunol Methods, 160 (1), 107-15
DOI 10.1016/0022-1759(93)90014-x, PubMed 7680696

Harboe M (1992)
[Gerhard Henrik Armauer Hansen--still of current interest]
Tidsskr Nor Laegeforen, 112 (30), 3795-8
PubMed 1485294

Rambukkana A, Das PK, Burggraaf JD, Yong S, Faber WR, Thole JE, Harboe M (1992)
Heterogeneity of monoclonal antibody-reactive epitopes on mycobacterial 30-kilodalton-region proteins and the secreted antigen 85 complex and demonstration of antigen 85B on the Mycobacterium leprae cell wall surface
Infect Immun, 60 (12), 5172-81
DOI 10.1128/IAI.60.12.5172-5181.1992, PubMed 1280626

Høgåsen K, Mollnes TE, Harboe M (1992)
Heparin-binding properties of vitronectin are linked to complex formation as illustrated by in vitro polymerization and binding to the terminal complement complex
J Biol Chem, 267 (32), 23076-82
PubMed 1385412

Rambukkana A, Das PK, Burggraaf JD, Faber WR, Teeling P, Krieg S, Thole JE, Harboe M (1992)
Identification and characterization of epitopes shared between the mycobacterial 65-kilodalton heat shock protein and the actively secreted antigen 85 complex: their in situ expression on the cell wall surface of Mycobacterium leprae
Infect Immun, 60 (11), 4517-27
DOI 10.1128/IAI.60.11.4517-4527.1992, PubMed 1383151

Harboe M, Wiker HG (1992)
The 38-kDa protein of Mycobacterium tuberculosis: a review
J Infect Dis, 166 (4), 874-84
DOI 10.1093/infdis/166.4.874, PubMed 1527425

Harboe M (1992)
The significance of proteins actively secreted by Mycobacterium tuberculosis in relation to immunity and complications of mycobacterial diseases
Int J Lepr Other Mycobact Dis, 60 (3), 470-6
PubMed 1474286

Wiker HG, Nagai S, Harboe M, Ljungqvist L (1992)
A family of cross-reacting proteins secreted by Mycobacterium tuberculosis
Scand J Immunol, 36 (2), 307-19
DOI 10.1111/j.1365-3083.1992.tb03104.x, PubMed 1502498

Salata RA, Sanson AJ, Malhotra IJ, Wiker HG, Harboe M, Phillips NB, Daniel TM (1991)
Purification and characterization of the 30,000 dalton native antigen of Mycobacterium tuberculosis and characterization of six monoclonal antibodies reactive with a major epitope of this antigen
J Lab Clin Med, 118 (6), 589-98
PubMed 1720803

Mollnes TE, Videm V, Riesenfeld J, Garred P, Svennevig JL, Fosse E, Hogasen K, Harboe M (1991)
Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials
Clin Exp Immunol, 86 Suppl 1, 21-6
PubMed 1934602

Abou-Zeid C, Garbe T, Lathigra R, Wiker HG, Harboe M, Rook GA, Young DB (1991)
Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins
Infect Immun, 59 (8), 2712-8
DOI 10.1128/IAI.59.8.2712-2718.1991, PubMed 1830294

Mollnes TE, Videm V, Götze O, Harboe M, Oppermann M (1991)
Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin
Ann Thorac Surg, 52 (1), 92-7
DOI 10.1016/0003-4975(91)91426-v, PubMed 2069469

Wiker HG, Harboe M, Nagai S (1991)
A localization index for distinction between extracellular and intracellular antigens of Mycobacterium tuberculosis
J Gen Microbiol, 137 (4), 875-84
DOI 10.1099/00221287-137-4-875, PubMed 1906925

Jellum E, Harboe M, Bjune G, Wold S (1991)
Interpreting complicated chromatographic patterns
J Pharm Biomed Anal, 9 (8), 663-9
DOI 10.1016/0731-7085(91)80193-d, PubMed 1790187

Nagai S, Wiker HG, Harboe M, Kinomoto M (1991)
Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis
Infect Immun, 59 (1), 372-82
DOI 10.1128/IAI.59.1.372-382.1991, PubMed 1898899

Olmez U, Garred P, Mollnes TE, Harboe M, Berntzen HB, Munthe E (1991)
C3 activation products, C3 containing immune complexes, the terminal complement complex and native C9 in patients with rheumatoid arthritis
Scand J Rheumatol, 20 (3), 183-9
DOI 10.3109/03009749109103019, PubMed 2068540

Harboe M, Wiker HG, Lachmann PJ (1990)
Carrier effect of concanavalin A-reactive and -non-reactive material in tuberculin PPD
Scand J Immunol, 32 (3), 263-71
DOI 10.1111/j.1365-3083.1990.tb02919.x, PubMed 2402595

Wiker HG, Harboe M (1990)
Integration of monoclonal antibodies in quantitative immunoelectrophoresis by indirect immunoprecipitation
J Immunol Methods, 132 (1), 127-35
DOI 10.1016/0022-1759(90)90406-l, PubMed 2202762

Harboe M, Wiker HG, Duncan JR, Garcia MM, Dukes TW, Brooks BW, Turcotte C, Nagai S (1990)
Protein G-based enzyme-linked immunosorbent assay for anti-MPB70 antibodies in bovine tuberculosis
J Clin Microbiol, 28 (5), 913-21
DOI 10.1128/JCM.28.5.913-921.1990, PubMed 2191012

Wiker HG, Harboe M, Nagai S, Bennedsen J (1990)
Quantitative and qualitative studies on the major extracellular antigen of Mycobacterium tuberculosis H37Rv and Mycobacterium bovis BCG
Am Rev Respir Dis, 141 (4 Pt 1), 830-8
DOI 10.1164/ajrccm/141.4_Pt_1.830, PubMed 2109556

Fossum S, Harboe M, Thorsby E, Gundersen D (1989)
[Norwegian nomenclature in immunology]
Tidsskr Nor Laegeforen, 109 (7-8), 853-5
PubMed 2705171

Lai A Fat RF, Harboe M, Chan Pin Jin JC, Diesselhoff-den Dulk MM, van Furth R (1988)
In vitro synthesis of antimycobacterial antibodies with different specificities in various tissues of leprosy patients
Int J Lepr Other Mycobact Dis, 56 (4), 552-8
PubMed 3065420

Abou-Zeid C, Ratliff TL, Wiker HG, Harboe M, Bennedsen J, Rook GA (1988)
Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG
Infect Immun, 56 (12), 3046-51
DOI 10.1128/IAI.56.12.3046-3051.1988, PubMed 3141278

Int. J. Lepr. Other Mycobact. Dis., 56 (4), 552-558

Wiker HG, Harboe M, Bennedsen J, Closs O (1988)
The antigens of Mycobacterium tuberculosis, H37Rv, studied by crossed immunoelectrophoresis. Comparison with a reference system for Mycobacterium bovis, BCG
Scand J Immunol, 27 (2), 223-39
DOI 10.1111/j.1365-3083.1988.tb02342.x, PubMed 3124264

Menzel S, Harboe M, Bergsvik H, Brennan PJ (1987)
Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy
Int J Lepr Other Mycobact Dis, 55 (4), 617-25
PubMed 3323365

Mollnes TE, Harboe M (1987)
Immunohistochemical detection of the membrane and fluid-phase terminal complement complexes C5b-9(m) and SC5b-9. Consequences for interpretation and terminology
Scand J Immunol, 26 (4), 381-6
DOI 10.1111/j.1365-3083.1987.tb02270.x, PubMed 3685888

De Bruyn J, Huygen K, Bosmans R, Fauville M, Lippens R, Van Vooren JP, Falmagne P, Weckx M, Wiker HG, Harboe M (1987)
Purification, characterization and identification of a 32 kDa protein antigen of Mycobacterium bovis BCG
Microb Pathog, 2 (5), 351-66
DOI 10.1016/0882-4010(87)90077-5, PubMed 3148811

Wiker HG, Harboe M (1987)
Comparison of antigens and antisera in crossed immunoelectrophoresis by dual dilution
J Immunol Methods, 97 (2), 201-7
DOI 10.1016/0022-1759(87)90460-1, PubMed 3102615

Harboe M, Ivanyi J (1987)
Analysis of monoclonal antibodies to Mycobacterium leprae by crossed immunoelectrophoresis
Scand J Immunol, 25 (2), 133-8
DOI 10.1111/j.1365-3083.1987.tb01056.x, PubMed 3547616

De Bruyn J, Bosmans R, Turneer M, Weckx M, Nyabenda J, Van Vooren JP, Falmagne P, Wiker HG, Harboe M (1987)
Purification, partial characterization, and identification of a skin-reactive protein antigen of Mycobacterium bovis BCG
Infect Immun, 55 (1), 245-52
DOI 10.1128/IAI.55.1.245-252.1987, PubMed 3539805

Gill HK, Mustafa AS, Ivanyi J, Harboe M, Godal T (1986)
Humoral immune responses to M. leprae in human volunteers vaccinated with killed, armadillo-derived M. leprae
Lepr Rev, 57 Suppl 2, 293-300
PubMed 3553802

Harboe M, Wiker HG (1986)
Immunological and biochemical characterization and classification of mycobacterial antigens
Lepr Rev, 57 Suppl 2, 33-7
DOI 10.5935/0305-7518.19860052, PubMed 3573945

Olcén P, Harboe M, Warndorff van Diepen T (1986)
Antigens of Mycobacterium leprae in urine during treatment of patients with lepromatous leprosy
Lepr Rev, 57 (4), 329-40
PubMed 3540495

Harboe M (1986)
Functions of an external medical advisory committee
Lepr Rev, 57 Suppl 1, 41-6
PubMed 3586834

Harboe M (1986)
Functions of an external medical advisory committee
Ethiop Med J, 24 Suppl 1, 41-6
PubMed 3608999

Mollnes TE, Ng YC, Peters DK, Lea T, Tschopp J, Harboe M (1986)
Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro
Clin Exp Immunol, 65 (1), 73-9
PubMed 3641694

Mollnes TE, Lea T, Mellbye OJ, Pahle J, Grand O, Harboe M (1986)
Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex
Arthritis Rheum, 29 (6), 715-21
DOI 10.1002/art.1780290603, PubMed 3718564

Harboe M, Nagai S, Patarroyo ME, Torres ML, Ramirez C, Cruz N (1986)
Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG
Infect Immun, 52 (1), 293-302
DOI 10.1128/IAI.52.1.293-302.1986, PubMed 3514457

Wiker HG, Harboe M, Nagai S, Patarroyo ME, Ramirez C, Cruz N (1986)
MPB59, a widely cross-reacting protein of Mycobacterium bovis BCG
Int Arch Allergy Appl Immunol, 81 (4), 307-14
DOI 10.1159/000234154, PubMed 3536756

Nagai S, Miura K, Tokunaga T, Harboe M (1986)
MPB70, a unique antigenic protein isolated from the culture filtrate of BCG substrain Tokyo
Dev Biol Stand, 58 ( Pt B), 511-6
PubMed 3301461

Wiker HG, Harboe M, Lea TE (1986)
Purification and characterization of two protein antigens from the heterogeneous BCG85 complex in Mycobacterium bovis BCG
Int Arch Allergy Appl Immunol, 81 (4), 298-306
DOI 10.1159/000234153, PubMed 3536755

Reitan LJ, Closs O, Harboe M (1985)
Characterization of the immune response to an epitope on Mycobacterium leprae antigen 7 defined by a monoclonal antibody
Scand J Immunol, 22 (6), 711-20
DOI 10.1111/j.1365-3083.1985.tb01934.x, PubMed 2418496

Mollnes TE, Lea T, Frøland SS, Harboe M (1985)
Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex
Scand J Immunol, 22 (2), 197-202
DOI 10.1111/j.1365-3083.1985.tb01871.x, PubMed 2412280

Mollnes TE, Lea T, Harboe M, Tschopp J (1985)
Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma
Scand J Immunol, 22 (2), 183-95
DOI 10.1111/j.1365-3083.1985.tb01870.x, PubMed 4035298

Fosse E, Svennevig JL, Harboe M (1985)
Cell markers in stored blood
Injury, 16 (6), 393-7
DOI 10.1016/0020-1383(85)90054-3, PubMed 4008032

Abou-Zeid C, Harboe M, Sundsten B, Cocito C (1985)
Cross-reactivity of antigens from the cytoplasm and cell walls of some corynebacteria and mycobacteria
J Infect Dis, 151 (1), 170-8
DOI 10.1093/infdis/151.1.170, PubMed 3965589

Mollnes TE, Frøland SS, Harboe M (1985)
Increased plasma levels of the terminal complement complex in patients with evidence of complement activation
Complement, 2 (2-3), 175-84
DOI 10.1159/000467858, PubMed 3878765

Mollnes TE, Lea T, Harboe M (1984)
Detection and quantification of the terminal C5b-9 complex of human complement by a sensitive enzyme-linked immunosorbent assay
Scand J Immunol, 20 (2), 157-66
DOI 10.1111/j.1365-3083.1984.tb00989.x, PubMed 6474098

Olcén P, Harboe M, Warndorff T, Belehu A (1984)
Anti-Mycobacterium leprae antibodies in urine from lepromatous patients examined by crossed immunoelectrophoresis and radioimmunoassay
Scand J Immunol, 19 (6), 521-8
DOI 10.1111/j.1365-3083.1984.tb00963.x, PubMed 6377478

Harboe M, Nagai S (1984)
MPB70, a unique antigen of Mycobacterium bovis BCG
Am Rev Respir Dis, 129 (3), 444-52
DOI 10.1164/arrd.1984.129.3.444, PubMed 6367574

Rao AS, Liao J, Kabat EA, Osserman EF, Harboe M, Nimmich W (1984)
Immunochemical studies on human monoclonal macroglobulins with specificities for 3,4-pyruvylated D-galactose and 4,6-pyruvylated D-glucose
J Biol Chem, 259 (2), 1018-26
PubMed 6693372

Mshana RN, Humber DP, Harboe M, Belehu A (1983)
Demonstration of mycobacterial antigens in nerve biopsies from leprosy patients using peroxidase-antiperoxidase immunoenzyme technique
Clin Immunol Immunopathol, 29 (3), 359-68
DOI 10.1016/0090-1229(83)90039-9, PubMed 6416726

Mshana RN, Humber DP, Harboe M, Belehu A (1983)
Immune responses to bovine neural antigens in leprosy patients. II. Absence of in vitro lymphocyte stimulation to peripheral nerve myelin proteins
Lepr Rev, 54 (3), 217-27
DOI 10.5935/0305-7518.19830029, PubMed 6195500

Olcén P, Harboe M, Warndorff T, Belehu A (1983)
Antigens of Mycobacterium leprae and anti-M. leprae antibodies in the urine of leprosy patients
Lepr Rev, 54 (3), 203-16
DOI 10.5935/0305-7518.19830028, PubMed 6355725

Touw Langendijk EJ, van Diepen TW, Harboe M, Belehu A (1983)
Relation between anti-Mycobacterium leprae antibody activity and clinical features in borderline tuberculoid (BT) leprosy
Int J Lepr Other Mycobact Dis, 51 (3), 305-11
PubMed 6358061

Dahle JS, van Diepen TW, Touw Langendijk EJ, Harboe M, Belehu A (1983)
Effect of treatment on antibody activity against Mycobacterium leprae antigen 7 in tuberculoid leprosy
Int J Lepr Other Mycobact Dis, 51 (3), 312-20
PubMed 6358062

Gueur MC, Harboe M, Fontaine F, Delville J, Cocito C (1983)
Comparison of the cytoplasmic antigens of leprosy-derived corynebacteria and some mycobacteria
Scand J Immunol, 17 (6), 497-506
DOI 10.1111/j.1365-3083.1983.tb00817.x, PubMed 6191381

Mshana RN, Humber DP, Harboe M, Belehu A (1983)
Nerve damage following intraneural injection of Mycobacterium leprae into rabbits pre-sensitized to mycobacteria
Clin Exp Immunol, 52 (2), 441-8
PubMed 6345041

Harboe M (1983)
The work and concepts of Armauer Hansen: how do they stand today?
Ethiop Med J, 21 (2), 123-6
PubMed 6343074

Mshana RN, Harboe M, Stoner GL, Hughes RA, Kadlubowski M, Belehu A (1983)
Immune responses to bovine neural antigens in leprosy patients. I. Absence of antibodies to an isolated myelin protein
Int J Lepr Other Mycobact Dis, 51 (1), 33-40
PubMed 6190769

Mshana RN, Humber DP, Belehu A, Harboe M (1983)
Immunohistological studies of skin biopsies from patients with lepromatous leprosy
J Clin Immunol, 3 (1), 22-9
DOI 10.1007/bf00919135, PubMed 6338025

Int. J. Lepr. Other Mycobact. Dis., 51 (3), 305-311

Melsom R, Harboe M, Duncan ME (1982)
IgA, IgM and IgG anti-M. leprae antibodies in babies of leprosy mothers during the first 2 years of life
Clin Exp Immunol, 49 (3), 532-42
PubMed 6756719

Mshana RN, Haregewoin A, Harboe M, Belehu A (1982)
Thymus dependent lymphocytes in leprosy. I. T lymphocyte subpopulations defined by monoclonal antibodies
Int J Lepr Other Mycobact Dis, 50 (3), 291-6
PubMed 6216220

Melsom R, Harboe M, Naafs B (1982)
Class specific anti-Mycobacterium leprae antibody assay in lepromatous leprosy (BL-LL) patients during the first two to four years of DDS treatment
Int J Lepr Other Mycobact Dis, 50 (3), 271-81
PubMed 6754639

Closs O, Reitan LJ, Negassi K, Harboe M, Belehu A (1982)
In vitro stimulation of lymphocytes in leprosy patients, healthy contacts of leprosy patients, and subjects not exposed to leprosy. Comparison of an antigen fraction prepared from Mycobacterium leprae and tuberculin-purified protein derivative
Scand J Immunol, 16 (2), 103-15
DOI 10.1111/j.1365-3083.1982.tb00704.x, PubMed 6182610

Andersen O, Jantzen E, Closs O, Harboe M, Saxegaard F, Fodstad F (1982)
Fatty acid and polar lipid analysis as tools in the identification of Mycobacterium leprae and some related slow-growing mycobacterial species
Ann Microbiol (Paris), 133 (1), 29-37
PubMed 7051927

Mshana RN, Belehu A, Stoner GL, Harboe M, Haregewoin A (1982)
Demonstration of mycobacterial antigens in leprosy tissues
Int J Lepr Other Mycobact Dis, 50 (1), 1-10
PubMed 7042609

Melsom R, Harboe M, Myrvang B, Godal T, Belehu A (1982)
Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy
Clin Exp Immunol, 47 (2), 225-33
PubMed 7042137

ANN INST PASTEUR MIC, B133 (1), 29-37

Harboe M (1981)
Mycobacterium leprae and the host response
Lepr Rev, 52 Suppl 1, 1-14
PubMed 7040872

Harboe M (1981)
Radioimmunoassay and other serologic tests and their application in epidemiological work
Lepr Rev, 52 Suppl 1, 275-88
DOI 10.5935/0305-7518.19810077, PubMed 7040881

Melsom R, Harboe M, Duncan ME, Bergsvik H (1981)
IgA and IgM antibodies against Mycobacterium leprae in cord sera and in patients with leprosy: an indicator of intrauterine infection in leprosy
Scand J Immunol, 14 (4), 343-52
DOI 10.1111/j.1365-3083.1981.tb00574.x, PubMed 7038849

Harboe M (1981)
Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis
Am Rev Respir Dis, 124 (1), 80-7
DOI 10.1164/arrd.1981.124.1.80, PubMed 7020505

Harboe M, Closs O, Reitan LJ, Draper P (1981)
Demonstration of antibodies reacting with different determinants on Mycobacterium leprae antigen 7
Int J Lepr Other Mycobact Dis, 49 (2), 147-58
PubMed 6168595

Harboe M, Closs O (1981)
A claim for a Mycobacterium leprae specific antigen
Int J Lepr Other Mycobact Dis, 49 (1), 85-9
PubMed 6788723

Widebäck K, Kronvall G, Bjorvatn B, Closs O, Harboe M (1980)
Comparative studies of antigen 21 in Mycobacterium and Nocardia species: possible taxonomic relationships with Mycobacterium leprae
Infect Immun, 30 (2), 413-20
PubMed 7002798

Harboe M (1980)
Anders Jahre's medical prizes for 1980 (Björn Folkow, Fredrik Kiil, Jens F Rehfeld, Lars Terenius)
J Oslo City Hosp, 30 (11-12), 137-43
PubMed 7012283

Melsom R, Duncan ME, Harboe M, Bjune G (1980)
Antibodies against Mycobacterium leprae antigen 7 from birth to 18 months of age: an indicator of intra-uterine infection in leprosy
Clin Exp Immunol, 42 (1), 107-13
PubMed 7006873

Harboe M (1980)
Immunological aspects of leprosy: ten years' activity at the Armauer Hansen Research Institute and Prospects for further work
Int J Lepr Other Mycobact Dis, 48 (2), 193-205
PubMed 6156919

Lai A Fat RF, Chan Pin Jin J, van Furth R, Harboe M (1980)
In vitro synthesis of anti-mycobacterial antibodies in biopsies from skin lesions of leprosy patients
Infect Immun, 27 (2), 297-301
DOI 10.1128/IAI.27.2.297-301.1980, PubMed 6991410

Dworsky E, Sletten K, Harboe M, Wetteland P (1980)
Structural studies of three IgG kappa proteins from a patient with multiple myeloma
Scand J Immunol, 12 (4), 281-7
DOI 10.1111/j.1365-3083.1980.tb00068.x, PubMed 6781064

Closs O, Harboe M, Axelsen NH, Bunch-Christensen K, Magnusson M (1980)
The antigens of Mycobacterium bovis, strain BCG, studied by crossed immunoelectrophoresis: a reference system
Scand J Immunol, 12 (3), 249-63
DOI 10.1111/j.1365-3083.1980.tb00065.x, PubMed 7008186

Negassi K, Closs O, Harboe M (1979)
Cross-reactions between serum proteins and water soluble liver tissue antigens of the nine-banded armadillo (Dasypus novemcinctus Linn.) and man
Clin Exp Immunol, 38 (1), 135-47
PubMed 93527

Yoder L, Naafs B, Harboe M, Bjune G (1979)
Antibody activity against Mycobacterium leprae antigen 7 in leprosy: studies on variation in antibody content throughout the spectrum and on the effect of DDS treatment and relapse in BT leprosy
Lepr Rev, 50 (2), 113-21
DOI 10.5935/0305-7518.19790017, PubMed 396427

Fagreus A, Harboe M, Natvig JB (1979)
Albert Coons, 1912--78
Scand J Immunol, 9 (5), 395-6
DOI 10.1111/j.1365-3083.1979.tb03179.x, PubMed 379980

Harboe M, Mshana RN, Closs O, Kronvall G, Axelsen NH (1979)
Cross-reactions between mycobacteria. II. Crossed immunoelectrophoretic analysis of soluble antigens of BCG and comparison with other mycobacteria
Scand J Immunol, 9 (2), 115-24
DOI 10.1111/j.1365-3083.1979.tb02713.x, PubMed 106465

Mshana RN, Closs O, Harboe M (1979)
Antibody response in rabbits to Mycobacterium bovis BCG
Scand J Immunol, 9 (2), 175-82
DOI 10.1111/j.1365-3083.1979.tb02720.x, PubMed 370972

Harboe M, Closs O, Rees RJ, Walsh GP (1978)
Formation of antibody against Mycobacterium leprae antigen 7 in armadillos
J Med Microbiol, 11 (4), 525-35
DOI 10.1099/00222615-11-4-525, PubMed 364069

Melsom R, Naafs B, Harboe M, Closs O (1978)
Antibody activity against Mycobacterium leprae antigen 7 during the first year of DDS treatment in lepromatous (BL-LL) leprosy
Lepr Rev, 49 (1), 17-29
PubMed 347205

Negassi K, Closs O, Harboe M (1978)
False spurs in quantitative immunoelectrophoresis
Scand J Immunol, 8 (4), 279-90
DOI 10.1111/j.1365-3083.1978.tb00521.x, PubMed 82271

Svennevig JL, Closs O, Harboe M, Svaar H (1978)
Characterization of lymphocytes isolated from non-lymphoid human malignant tumours
Scand J Immunol, 7 (6), 487-93
DOI 10.1111/j.1365-3083.1978.tb00482.x, PubMed 356179

Harboe M, Closs O, Bjune G, Kronvall G, Axelsen NH (1978)
Mycobacterium leprae specific antibodies detected by radioimmunoassay
Scand J Immunol, 7 (2), 111-20
DOI 10.1111/j.1365-3083.1978.tb00433.x, PubMed 77549

Harboe M, Closs O, Bjorvatn B, Kronvall G, Axelsen NH (1977)
Antibody response in rabbits to immunization with Mycobacterium leprae
Infect Immun, 18 (3), 792-805
DOI 10.1128/IAI.18.3.792-805.1977, PubMed 338491

Harboe M, Closs O, Bjorvatn B, Bjune G (1977)
Antibodies against BCG antigen 60 in mycobacterial infection
Br Med J, 2 (6084), 430-3
DOI 10.1136/bmj.2.6084.430, PubMed 407965

Harboe M, Closs O, Svindahl K, Deverill J (1977)
Production and assay of antibodies against one antigenic component of Mycobacterium bovis BCG
Infect Immun, 16 (2), 662-72
DOI 10.1128/IAI.16.2.662-672.1977, PubMed 324917

Harboe M (1976)
Importance of immune reactions in leprosy
Ethiop Med J, 14 (4), 205-12
PubMed 799966

Harboe M, Folling I (1976)
Sudden death caused by interaction between a macroglobulin and a divalent drug
Lancet, 2 (7980), 285-9
DOI 10.1016/s0140-6736(76)90734-0, PubMed 59856

Axelsen NH, Harboe M, Jonsson V, Videbaek AA (1976)
Mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. II. Immunochemical studies
Scand J Haematol, 16 (3), 218-25
DOI 10.1111/j.1600-0609.1976.tb01141.x, PubMed 179131

Jonsson V, Videbek A, Axelsen NH, Harboe M (1976)
mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. I. Clinical aspects
Scand J Haematol, 16 (3), 209-17
DOI 10.1111/j.1600-0609.1976.tb01140.x, PubMed 179130

Harboe M, Closs O, Deverill J (1976)
Production of monospecific antisera against antigenic componentsof Mycobacterium bovis (BCG)
Scand J Immunol, 5 (6-7), 861-6
DOI 10.1111/j.1365-3083.1976.tb03035.x, PubMed 790542

Saltvedt E, Harboe M (1976)
Binding of IgA to protein-A-containing staphylococci: relationship to subclasses
Scand J Immunol, 5 (10), 1103-8
DOI 10.1111/j.1365-3083.1976.tb00250.x, PubMed 1013646

Eskeland T, Harboe M (1975)
Common idiotypic antigenic determinants on monomeric (7S) and polymeric IgM from the same serum
Scand J Immunol, 4 (5-6), 583-90
DOI 10.1111/j.1365-3083.1975.tb02664.x, PubMed 52185

ACTA PATH MICRO IM C, 83 (2), 97-105

ACTA PATH MICRO IM C, 83 (2), 106-111

Scand. J. Immunol. (2), 125-134

Saltvedt E, Harboe M, Følling I, Olsnes S (1975)
Interactions between ricinus agglutinin and human IgM and IgG
Scand J Immunol, 4 (3), 287-94
DOI 10.1111/j.1365-3083.1975.tb02628.x, PubMed 1080291

Scand. J. Immunol. (2), 173-185

Harboe M, Andersen PM, Foltmann B, Kay J, Kassell B (1974)
The activation of bovine pepsinogen. Sequence of the peptides released, identification of a pepsin inhibitor
J Biol Chem, 249 (14), 4487-94
PubMed 4603017

Harboe M (1974)
[The immunologists take a look at cell membrane]
Tidsskr Nor Laegeforen, 94 (19), 1271-2
PubMed 4845302

Axelsen NH, Harboe M, Closs O, Godal T (1974)
BCG antibody profiles in tuberculoid and lepromatous leprosy
Infect Immun, 9 (5), 952-8
DOI 10.1128/IAI.9.5.952-958.1974, PubMed 4207518

Harboe M (1974)
[Immunological aspects of acquired hemolytic anemia]
Tidsskr Nor Laegeforen, 94 (5), 312-5
PubMed 4544871

Harboe M, Fölling I (1974)
Recognition of two distinct groups of human IgM and IgA based on different binding to staphylococci
Scand J Immunol, 3 (4), 471-82
DOI 10.1111/j.1365-3083.1974.tb01280.x, PubMed 4212304

Husby G, Natvig JB, Harboe M (1974)
The occurrence in sera with m-components of different proteins related to amyloid fibrils
Scand J Immunol, 3 (4), 391-6
DOI 10.1111/j.1365-3083.1974.tb01271.x, PubMed 4212436

Harboe M, Folling I (1974)
Complex formation between monoclonal IgM and albumin
Scand J Immunol, 3 (1), 51-60
DOI 10.1111/j.1365-3083.1974.tb01232.x, PubMed 4208200

Jakobsen A, Flatmark A, Harboe M (1973)
Rabbit anti rat lymphocyte serum: immunosuppression mediated by a pure IgM fraction
Acta Pathol Microbiol Scand B Microbiol Immunol, 81 (5), 635-40
DOI 10.1111/j.1699-0463.1973.tb02254.x, PubMed 4209178

Harboe M (1973)
Armauer Hansen--the man and his work
Int J Lepr Other Mycobact Dis, 41 (4), 417-24
PubMed 4601451

Harboe M, Foltmann B (1973)
The N-terminal amino acid sequence of bovine pepsin (EC and the sequence overlapping the activation fragment
FEBS Lett, 34 (2), 311-4
DOI 10.1016/0014-5793(73)80819-1, PubMed 4583851

Harboe M (1973)
[Scandinavian leprosy conference in Bergen. What do we know about leprosy and what do we do about it?]
Nord Med, 88 (6), 186-9
PubMed 4778889

Harboe M (1973)
Immunoglobulins with special reference to cell-bound immunoglobulins
Ethiop Med J, 11 (2), 171-2
PubMed 4545243

Eskeland T, Harboe M (1973)
7S immunoglobulin M (IgM) from serum purified by anti-mu-chain immunoadsorbent: comparison of the reassociation properties of 7S IgM and various 19S IgM subunits
Scand J Immunol, 2 (5), 511-22
DOI 10.1111/j.1365-3083.1973.tb02057.x, PubMed 4204578

ACTA PATH MICRO IM B, B 81 (5), 635-640

Harboe M (1972)
[Nobel prize for immunoglobulin research]
Tidsskr Nor Laegeforen, 92 (34), 2363-5
PubMed 4568120

Solheim BG, Harboe M (1972)
Reversible dissociation of reduced and alkylated IgM subunits to half subunits
Immunochemistry, 9 (6), 623-34
DOI 10.1016/0019-2791(72)90248-0, PubMed 5041241

Harboe M (1972)
Tidsskr Nor Laegeforen, 92 (11), 793-4
PubMed 5028902

Harboe M, Solheim BG (1972)
Formation of hybrid IgM subunits
Scand J Immunol, 1 (1), 63-73
DOI 10.1111/j.1365-3083.1972.tb03736.x, PubMed 4627538

Harboe M, Hannestad K, Sletten K (1972)
Oligoclonal macroglobulinaemia
Scand J Immunol, 1 (1), 13-26
DOI 10.1111/j.1365-3083.1972.tb03731.x, PubMed 4116376

Harboe M (1971)
Quantitation of human serum immunoglobulins
Scand J Clin Lab Invest, 28 (3), 241
PubMed 5135091

Solheim BG, Harboe M, Deverill J (1971)
Individual antigenic specificity of human macroglobulins. II. Dependence of an antigenic determinant on the disulfide bond between the and kappa chains
Immunochemistry, 8 (10), 939-49
PubMed 4114318

Sudarsanam A, Grabosz J, Myklestad B, Myrvang B, Harboe M (1971)
Experimental Arthus reactions using the same antigen in soluble and corpuscular form
Afr J Med Sci, 2 (4), 319-28
PubMed 4255853

Harboe M, Vandvik B (1971)
[Immunological diagnosis in hypergammaglobulinemia]
Tidsskr Nor Laegeforen, 91 (23), 1641-7
PubMed 5110439

Natvig JB, Harboe M, Fausa O, Tveit A (1971)
Family studies in individuals with selective absence of gamma-A-globulin
Clin Exp Immunol, 8 (2), 229-36
PubMed 4995563

Stavem P, Harboe M (1971)
Acute erythroleukaemia in a patient treated with melphalan for the cold agglutinin syndrome
Scand J Haematol, 8 (5), 375-9
DOI 10.1111/j.1600-0609.1971.tb00887.x, PubMed 5289695

Stavem P, Harboe M (1971)
[Acute erythroleukemia in a melphalan-treated patient with cold agglutination syndrome]
Nord Med, 86 (49), 1494
PubMed 5289909

Hannestad K, Eriksen J, Christensen T, Harboe M (1970)
Multiple M-components in a single individual. I. The structural relationship of two serum gamma M kappa M-components as revealed by combining specificity and individual antigenic specificity
Immunochemistry, 7 (11), 899-915
PubMed 4099674

Harboe M (1969)
[The year's Jahre Prize winners: Hans Bennich, Docent, M. D., and S. Gunnar O. Johansson, Docent, M. D., Academic Hospital, Uppsala]
Tidsskr Nor Laegeforen, 89 (11), 840
PubMed 4183801

Harboe M, Solheim BG, Deverill J (1969)
Individual antigenic specificity of human macroglobulins: Localization of antigenic determinants and their use to demonstrate formation of hybrid molecules after reduction and reassociation
J Exp Med, 129 (6), 1217-34
DOI 10.1084/jem.129.6.1217, PubMed 4977279

Seip M, Harboe M, Cyvin K (1969)
Chronic autoimmune hemolytic anemia in childhood with cold antibodies, aplastic crises, and familial occurrence
Acta Paediatr Scand, 58 (3), 275-80
DOI 10.1111/j.1651-2227.1969.tb04717.x, PubMed 5783414

Harboe M, Torsvik H (1969)
Protein abnormalities in the cold haemagglutinin syndrome
Scand J Haematol, 6 (6), 416-26
DOI 10.1111/j.1600-0609.1969.tb01836.x, PubMed 4984643

Harboe M (1967)
Absorption and control of specificity of antisera
Scand J Clin Lab Invest Suppl, 100, 9
PubMed 4166858

Tönder O, Harboe M (1966)
Heterogeneity of cold haemagglutinins
Immunology, 11 (4), 361-8
PubMed 5924621

Harboe M (1966)
[We interview Erik Kåss, professor and physician at the Oslo Medical Society Rheumatism Hospital]
Tidsskr Nor Laegeforen, 86 (6), 403-4
PubMed 5330298

Harboe M, Deverill J (1966)
Structural relationship between gamma-G- and gamma-M-globulin in man
Acta Med Scand Suppl, 445, 74-9
PubMed 4160695

Ceppellini R, Dray S, Fahey JL, Franklin EC, Fudenberg H, Gell PG, Goodman HC, Grubb R, Harboe M, Kirk RL, Oudin J, Ropartz C, Smithies O, Steinberg AG, Trnka Z (1966)
[Nomenclature of genetically determined characteristics of human immunoglobulins]
Humangenetik, 2 (3), 317-22
DOI 10.1007/bf00395948, PubMed 4168284

HUMANGENETIK, 2 (3), 317

Harboe M, Pande H, Brandtzaeg P, Tveter KJ, Hjort PF (1966)
Synthesis of donor type gamma-G-globulin following thymus transplantation in hypo-gamma-globulinaemia with severe lymphocytopenia
Scand J Haematol, 3 (5), 351-74
DOI 10.1111/j.1600-0609.1966.tb02379.x, PubMed 4163435

Harboe M, Lind K (1966)
Light chain types of transiently occurring cold haemagglutinins
Scand J Haematol, 3 (4), 269-76
DOI 10.1111/j.1600-0609.1966.tb02371.x, PubMed 4958443

HARBOE M (1965)
Nord Med, 73, 640-1
PubMed 14299151

Harboe M (1965)
Reaction of I-131 trace labeled cold agglutinin
Ann N Y Acad Sci, 124 (2), 491-8
DOI 10.1111/j.1749-6632.1965.tb18983.x, PubMed 4953945

J Exp Med, 121, 503-19
DOI 10.1084/jem.121.4.503, PubMed 14276773

Vox Sang, 10, 225-7
DOI 10.1111/j.1423-0410.1965.tb04344.x, PubMed 14339234

HARBOE M (1965)
Tidsskr Nor Laegeforen, 85, 308-9
PubMed 14305805

HARBOE M (1965)
Nord Med, 73, 108-9
PubMed 14252376

Harboe M (1965)
Pepsin-splitting of gamma-M-globulins and high molecular weight antibodies
Scand J Clin Lab Invest, 17, Suppl 84:232+
PubMed 4159557

Heistö H, Harboe M, Godal HC (1965)
Warm haemolysins active against trypsinized red cells; occurrence, inheritance, and clinical significance
Bibl Haematol, 23, 787-9
DOI 10.1159/000384368, PubMed 4956292

Harboe M, van Furth R, Schubothe H, Lind K, Evans RS (1965)
Exclusive occurrence of K chains in isolated cold haemagglutinins
Scand J Haematol, 2 (3), 259-66
DOI 10.1111/j.1600-0609.1965.tb01303.x, PubMed 4158055

Scand J Haematol, 2, 137-47
PubMed 14341518

Immunology, 7, 403-18
PubMed 14193154

HARBOE M (1964)
Br J Haematol, 10, 339-46
DOI 10.1111/j.1365-2141.1964.tb00710.x, PubMed 14179488

Scand J Haematol, 1, 223-37
DOI 10.1111/j.1600-0609.1964.tb00019.x, PubMed 14214902

HARBOE M (1963)
Arthritis Rheum, 6, SUPPL 427-45
DOI 10.1002/art.1780060419, PubMed 14056855

Immunology, 6, 412-20
PubMed 14042906

Anti-gamma-globulin factors in human sera revealed by enzymatic splitting of anti-Rh antibodies
Vox Sang, 8, 133-52
DOI 10.1111/j.1423-0410.1963.tb03290.x, PubMed 13940587

Genetic characters of human gamma-globulins in myeloma proteins
J Exp Med, 116, 719-38
DOI 10.1084/jem.116.5.719, PubMed 13952722

Localization of two genetic factors to different areas of gamma-globulin molecules
Science, 136 (3520), 979-80
DOI 10.1126/science.136.3520.979, PubMed 14036038

Complement and complement components in acquired hemolytic anemia with high titer cold antibodies
Acta Med Scand, 170, 725-9
DOI 10.1111/j.0954-6820.1961.tb00291.x, PubMed 14452388

HARBOE M (1961)
Interactions of rheumatoid factor with immune precipitate containing antibody of human origin
Ann Rheum Dis, 20, 363-8
DOI 10.1136/ard.20.4.363, PubMed 13904576

Studies on a serum with peculiar haemagglutinating properties
Vox Sang, 6, 409-28
DOI 10.1111/j.1423-0410.1961.tb03187.x, PubMed 13904575

The application of the Gm system in paternity cases
Vox Sang, 6, 257-73
DOI 10.1111/j.1423-0410.1961.tb03162.x, PubMed 13711444

HARBOE M (1961)
[The rheumatoid factor]
Nord Med, 65, 216-7
PubMed 13711448

HARBOE M (1961)
Specificity of a rheumatoid factor
Acta Rheumatol Scand, 7, 13-7
DOI 10.3109/rhe1.1961.7.issue-1-4.02, PubMed 13711447

HARBOE M (1960)
Interactions between red cells coated with incomplete anti-D and rheumatoid sera
Acta Pathol Microbiol Scand, 50, 383-97
DOI 10.1111/j.1699-0463.1960.tb01208.x, PubMed 13711445

HARBOE M (1960)
Relation between Gm types and hemagglutinating substances in rheumatoid sera
Acta Pathol Microbiol Scand, 50, 89-105
DOI 10.1111/j.1699-0463.1960.tb01175.x, PubMed 13711446

HARBOE M (1959)
A new haemagglutinating substance in the Gm system, anti-Gm
Nature, 183 (4673), 1468-9
DOI 10.1038/1831468a0, PubMed 13657175

A new type in the Gm system
Acta Pathol Microbiol Scand, 45 (4), 357-70
DOI 10.1111/j.1699-0463.1959.tb04721.x, PubMed 13660835

HARBOE M (1959)
Quantitative studies on the hemagglutination inhibition reaction for determination of the Gm types
Acta Pathol Microbiol Scand, 47, 199-208
DOI 10.1111/j.1699-0463.1959.tb04849.x, PubMed 14399692

HARBOE M (1959)
A new hemagglutinating substance in the Gm system, anti-Gmb
Acta Pathol Microbiol Scand, 47, 191-8
DOI 10.1111/j.1699-0463.1959.tb04848.x, PubMed 14399693

HARBOE M (1959)
A method for determination of hemoglobin in plasma by near-ultraviolet spectrophotometry
Scand J Clin Lab Invest, 11, 66-70
DOI 10.3109/00365515909060410, PubMed 13646603

Ventilatory studies of the lungs during continuous pressure breathing
Acta Physiol Scand, 41 (1), 77-89
DOI 10.1111/j.1748-1716.1957.tb01511.x, PubMed 13497760

HARBOE M (1957)
Lactic acid content in human venous blood during hypoxia at high altitude
Acta Physiol Scand, 40 (2-3), 248-53
DOI 10.1111/j.1748-1716.1957.tb01494.x, PubMed 13469531

HARBOE M (1957)
The influence of methemoglobin and storage upon the spectrophotometric determination of carbon monoxide in blood
Scand J Clin Lab Invest, 9 (4), 317-21
PubMed 13495356

Review articles

Thorgersen EB, Barratt-Due A, Haugaa H, Harboe M, Pischke SE, Nilsson PH, Mollnes TE (2019)
The Role of Complement in Liver Injury, Regeneration, and Transplantation
Hepatology, 70 (2), 725-736
DOI 10.1002/hep.30508, PubMed 30653682

Harboe M, Thorgersen EB, Mollnes TE (2011)
Advances in assay of complement function and activation
Adv Drug Deliv Rev, 63 (12), 976-87
DOI 10.1016/j.addr.2011.05.010, PubMed 21664392

Castellheim A, Brekke OL, Espevik T, Harboe M, Mollnes TE (2009)
Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis
Scand J Immunol, 69 (6), 479-91
DOI 10.1111/j.1365-3083.2009.02255.x, PubMed 19439008

Harboe M, Mollnes TE (2008)
The alternative complement pathway revisited
J Cell Mol Med, 12 (4), 1074-84
DOI 10.1111/j.1582-4934.2008.00350.x, PubMed 18419792

Harboe M, Aseffa A, Leekassa R (2005)
Challenges presented by nerve damage in leprosy
Lepr Rev, 76 (1), 5-13
PubMed 15881032

Harboe M (2001)
[Immunology and control of tuberculosis]
Tidsskr Nor Laegeforen, 121 (1), 88-91
PubMed 12013623

Wiker HG, Harboe M (1992)
The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis
Microbiol Rev, 56 (4), 648-61
DOI 10.1128/MMBR.56.4.648-661.1992, PubMed 1480113

Harboe M, Wiker HG, Nagai S (1992)
Protein antigens of mycobacteria studied by quantitative immunologic techniques
Clin Infect Dis, 14 (1), 313-9
DOI 10.1093/clinids/14.1.313, PubMed 1571446

Harboe M (1988)
Rheumatoid factors in leprosy and parasitic diseases
Scand J Rheumatol Suppl, 75, 309-13
DOI 10.3109/03009748809096783, PubMed 3070728

Martin LN, Gormus BJ, Wolf RH, Walsh GP, Meyers WM, Binford CH, Harboe M (1984)
Experimental leprosy in nonhuman primates
Adv Vet Sci Comp Med, 28, 201-36
DOI 10.1016/b978-0-12-039228-5.50012-7, PubMed 6441464

Natvig JB, Harboe M (1971)
[Clinical immunology]
Tidsskr Nor Laegeforen, 91 (23), 1623-7
PubMed 4938859

Harboe M (1971)
[Immunological diagnosis in hematological diseases]
Tidsskr Nor Laegeforen, 91 (23), 1655-8
PubMed 4938861

Harboe M (1971)
Cold auto-agglutinins
Vox Sang, 20 (4), 289-305
DOI 10.1111/j.1423-0410.1971.tb00447.x, PubMed 4942296

Harboe M (1967)
[Genes and immunology]
Tidsskr Nor Laegeforen, 87 (5), Suppl:470-4
PubMed 4167292

HARBOE M (1964)
Tidsskr Nor Laegeforen, 84, 16-22
PubMed 14101792

HARBOE M (1964)
Tidsskr Nor Laegeforen, 84, 46-51
PubMed 14101798

Other articles

Capra JD, Frøland SS, Harboe M, Jonsson R, Ljunggren HG, Wigzell H (2009)
Professor emeritus Jacob B. Natvig, one of the founders of Scandinavian journal of immunology, turns 75
Scand J Immunol, 70 (6), 503-4
DOI 10.1111/j.1365-3083.2009.02343.x, PubMed 19906190

Harboe M (2007)
A new type in the Gm system - Commentary
APMIS, 115 (5), 556-557

Harboe M (2001)
25th Kellersberger memorial lecture, 2000. The contribution of immunology to tuberculosis control
Ethiop Med J, 39 (1), 75-82
PubMed 11338470

Harboe M (2000)
Robert N. Mshana, MD, Ph.D. 1954-2000 - Obituary
Int. J. Lepr. Other Mycobact. Dis., 68 (4), 475-476

Harboe M (2000)
Leprosy at a turning point?
Int J Lepr Other Mycobact Dis, 68 (3), 312-8
PubMed 11221095

Iyer A, Mistry N, Antia N, Harboe M (2000)
Clarification to Rada-Schlaefli, et al
Int J Lepr Other Mycobact Dis, 68 (1), 63-4
PubMed 10834071

Harboe M (1999)
Structure of the 15th International Leprosy Congress
Int. J. Lepr. Other Mycobact. Dis., 67 (1), 64-65

Natvig JB, Harboe M, Tonder O (1998)
Erik Waaler - in memoriam
Scand. J. Rheumatol., 27 (2), 89-90

Mistry NF, Iyer A, Harboe M, Antia NH (1996)
Low rates of detection of mycobacterial secretory antigen 85 in sera of untreated leprosy patients
Int J Lepr Other Mycobact Dis, 64 (4), 451-3
PubMed 9030114

Wieles B, Nagai S, Wiker HG, Harboe M, Ottenhoff TH (1995)
Identification and functional characterization of thioredoxin of Mycobacterium tuberculosis
Infect Immun, 63 (12), 4946-8
DOI 10.1128/IAI.63.12.4946-4948.1995, PubMed 7591163

Ulstrup JC, Jeansson S, Wiker HG, Harboe M (1995)
Relationship of secretion pattern and MPB70 homology with osteoblast-specific factor 2 to osteitis following Mycobacterium bovis BCG vaccination
Infect Immun, 63 (2), 672-5
DOI 10.1128/IAI.63.2.672-675.1995, PubMed 7822037

Osterland CK, Harboe M, Kunkel HG (1993)
Anti-gammaglobulin factors in human sera revealed by enzymatic splitting of anti-Rh antibodies. Vox Sang 1963;8:133-52
Vox Sang, 64 (4), 246-7
DOI 10.1111/j.1423-0410.1993.tb03065.x, PubMed 7685972

Stavem P, Harboe M (1992)
Does graft-violates-host disease give a better indication of what goes on than graft-versus-host disease?
J Intern Med, 232 (4), 372
PubMed 1402643

Harboe M, Quayle AJ (1991)
Heat shock proteins: friend and foe?
Clin Exp Immunol, 86 (1), 2-5
DOI 10.1111/j.1365-2249.1991.tb05764.x, PubMed 1914233

Garred P, Våge DI, Mollnes TE, Harboe M (1990)
Latex gloves as a cause of inflammation and eczema
Lancet, 335 (8703), 1469
DOI 10.1016/0140-6736(90)91502-2, PubMed 1972244

Wiker HG, Sletten K, Nagai S, Harboe M (1990)
Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex
Infect Immun, 58 (1), 272-4
DOI 10.1128/IAI.58.1.272-274.1990, PubMed 2403534

Abou-Zeid C, Harboe M, Rook GA (1987)
Characterization of the secreted antigens of Mycobacterium bovis BCG: comparison of the 46-kilodalton dimeric protein with proteins MPB64 and MPB70
Infect Immun, 55 (12), 3213-4
DOI 10.1128/IAI.55.12.3213-3214.1987, PubMed 3316036

Harboe M, Coates AR, Hewitt J (1985)
Characterization of the specificity of monoclonal antibodies against Mycobacterium tuberculosis by crossed immunoelectrophoresis
Scand J Immunol, 22 (1), 93-8
DOI 10.1111/j.1365-3083.1985.tb01863.x, PubMed 3927476

Harboe M (1982)
Significance of antibody studies in leprosy and experimental models of the disease
Int J Lepr Other Mycobact Dis, 50 (3), 342-50
PubMed 6754640

Int. J. Lepr. Other Mycobact. Dis., 49 (1), 86-88

Closs O, Mshana RN, Harboe M (1979)
Antigenic analysis of Mycobacterium leprae
Scand J Immunol, 9 (3), 297-302
DOI 10.1111/j.1365-3083.1979.tb02735.x, PubMed 373076

Harboe M (1979)
[Nil nocere]
Tidsskr Nor Laegeforen, 99 (1), 2-3
PubMed 760236

Lind I, Harboe M, Folling I (1975)
Protein A reactivity of two distinct groups of human monoclonal IgM
Scand J Immunol, 4 (8), 843-8
DOI 10.1111/j.1365-3083.1975.tb03726.x, PubMed 1215839

Sletten K, Hannestad K, Harboe M (1974)
On the frequency of valine in position 2 of the V k3 subgroup
Scand J Immunol, 3 (2), 215-8
DOI 10.1111/j.1365-3083.1974.tb01250.x, PubMed 4207151

Sletten K, Hannestad K, Harboe M (1974)
Immunochemical detection of the VkIV subgroup
Scand J Immunol, 3 (2), 219-22
DOI 10.1111/j.1365-3083.1974.tb01251.x, PubMed 4856661

Clin. Chim. Acta, 42 (2), 433-435


Poléo ABS, Johannessen HF, Harboe M (2001)
High voltage direct current (HVDC) sea cables and sea electrodes: effects on marine life: 1st revision of the literature study
University of Oslo, Oslo, 50 s.
BIBSYS 070201072

Harboe M (1994)
Faglig utvalg til vurdering av mulig helsefare knyttet til lavfrekvente elektromagnetiske felt: redegjørelse for utvalgets arbeid og rapporten til Sosial- og helsedepartementet ved presseseminaret 18. mai 1994
Utvalget, Oslo, 6 s.
BIBSYS 000269239

Harboe M, Natvig JB (1990)
Medisinsk immunologi
Stiftelsen medisinsk immunologi, Oslo (3. utg., rev.), 349 s.
BIBSYS 90078220x, ISBN 82-90225-04-0

Harboe M, Natvig JB (1987)
Medisinsk immunologi
Stiftelsen medisinsk immunologi, Oslo (3. utg.), 347 s.
BIBSYS 875020003, ISBN 87-7437-085-5

Harboe M, Natvig JB (1984)
Medisinsk immunologi
Stiftelsen medisinsk immunologi, Oslo (2. rev. utg.), 322 s.
BIBSYS 842153586, ISBN 82-90225-02-4

Harboe M, Natvig JB (1982)
Medisinsk immunologi
Stiftelsen medisinsk immunologi, [Oslo] (2. utg.), 311 s.
BIBSYS 835001067, ISBN 82-90225-01-6

Harboe M, Natvig JB (1975)
Medisinsk immunologi
Universitetsforlaget, Oslo, 257 s.
BIBSYS 855005181, ISBN 82-00-02362-1

Harboe M, Natvig JB (1975)
Medisinsk immunologi
Stiftelsen medisinsk immunologi, Oslo, 257 s.
BIBSYS 741136406, ISBN 82-90225-00-8

Harboe M (1961)
Tanker om kronisk polyarthrit: foredrag holdt på Norske kvinners sanitetsforenings kretsmøte for Oslo og Aker i september 1960
Oslo, 16 s.
BIBSYS 061886440

Book chapters

Harboe M (1998)
Immunforsvaret hos eldre
In Medicinsk årbog, Norli, Oslo, 1998, s. 39-42
BIBSYS 050243713

Harboe M (1996)
Helse og elektromagnetiske felt
In Medicinsk årbog, Norli, Oslo, 1996, s. 161-170
BIBSYS 042449499


Harboe M (1995)
Taurin effluks fra isolerte rotteleverceller ved hyposmotiske betingelser
[M. Harboe], Oslo, 63 s.
BIBSYS 951762907

Harboe M (1961)
Studies on the gamma globulin (Gm) serum groups
Oslo University press, Oslo, 1 b. (flere pag.)
BIBSYS 962298522

Page visits: 5323